RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B

Clinical Endocrinology

Volumn 67, Issue 4, 2007, Pages 570-576

  Zhou, Yulin ^a   Zhao, Yongju ^a   Cui, Bin ^a   Gu, Liqun ^a   Zhu, Shaoxin ^b   Li, Jianjun ^c   Liu, Jinbo ^d   Yin, Ming ^e   Zhao, Tieyun ^f   Yin, Zhiqiang ^a   Yu, Chaoli ^g   Chen, Changyou ^h   Wang, Liming ⁱ   Xiao, Buyun ^j   Hong, Jie ^a   Zhang, Yifei ^a   Tang, Zhengyi ^a   Wang, Shu ^a   Li, Xiaoying ^a   Ning, Guang ^a,k  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Xiehe Hospital   (China)

^c the Second Hospital   (China)

^d Electronic Centre Hospital   (China)

^e NINGBO UNIVERSITY   (China)

^f WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

^g TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^h Department of Endocrinology   (China)

ⁱ DALIAN MEDICAL UNIVERSITY   (China)

^j Guangji Hospital   (China)

^k SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PRIMER DNA; PROTEIN RET;

ADOLESCENT; ADULT; ARTICLE; CHINESE; CODON; CONTROLLED STUDY; DEMOGRAPHY; DNA DETERMINATION; DNA ISOLATION; EXON; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERPARATHYROIDISM; INCIDENCE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; PHEOCHROMOCYTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; SIPPLE SYNDROME; STATISTICAL SIGNIFICANCE; THYROID MEDULLARY CARCINOMA;

ADULT; AGED; CHINA; CODON; CROSS-SECTIONAL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; PEDIGREE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-RET;

EID: 34548700598     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02927.x     Document Type: Article

References (21)

1. Mulligan, L.M., Kwok, J.B., Healey, C.S., Elsdon, M.J., Eng, C., Gardner, E., Love, D.R., Mole, S.E., Moore, J.K., Papi, L., Ponder, M.A., Telenius, H., Tunnacliffe, A. Ponder, B.J. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature, 363, 458 460.
2. Hofstra, R.M., Landsvater, R.M., Ceccherini, I., Stulp, R.P., Stelwagen, T., Luo, Y., Pasini, B., Hoppener, J.W., van Amstel, H.K.P., Romeo, G., Lips, C.J.M. Buys, C.C.M. (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature, 367, 375 376.
3. Ponder, B.A. (1999) The phenotypes associated with RET mutations in the multiple endocrine neoplasia type 2 syndromes. Cancer Research, 59, 1736 1742.
4. Eng, C., Clayton, D., Schuffenecker, I., Lenoir, G., Cote, G., Gagel, R.F., Van Amstel, H.K.P., Lips, C.J.M., Nishisho, I., Takai, S.I., Marsh, D.J., Robinson, B.G., Frank-Raue, K., Raue, F., Xue, F., Noll, W.W., Romei, C., Pacini, F., Fink, M., Niederle, B., Zedenius, J., Nordenskjöld, M., Komminoth, P., Hendy, G.N., Gharib, H., Thibodeau, S.N., Lacroix, A. Frilling, A. (1996) The relationship between specific RET proto-oncogene mutation and disease phenotype in multiple endocrine neoplasia type 2. Journal of the American Medical Association, 276, 1575 1579.
5. Mulligan, L.M., Marsh, D.J., Robinson, B.G., Schuffeenecker, I., Zedenius, J., Lips, C.J.M., Gagel, R.F., Takai, S.I., Noll, W.W., Fink, M., Raue, F., Lacroix, A., Thibodeau, S.N., Frilling, A., Ponder, B.A.J. Eng, C. (1995) Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. Journal of Internal Medicine, 238, 343 346.
6. Niccoli-Sire, P., Murat, A., Rohmer, V., Frank, S., Chabrier, G., Baldet, L., Maes, B., Savagner, F., Giraud, S., Bezieau, S., Kottler, M.L., Morange, S. Conte-Devolx, B. (2001) Familial medullary thyroid carcinoma with noncysteine RET mutations: phenotype-genotype relationship in a large series of patients. Journal of Clinical Endocrinology and Metabolism, 86, 3746 3753.
7. Machens, A., Gimm, O., Hinze, R., Hoppner, W., Boehm, B.O. Dralle, H. (2001) Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties. Journal of Clinical Endocrinology and Metabolism, 86, 1104 1109.
8. Brandi, M.L., Gagel, R.F., Angeli, A., Bilezikian, J.P., Beck-Peccoz, P., Bordi, C., Conte-Devox, B., Falchetti, A., Gheri, R.G., Lobroia, A., Lips, C.J.M., Lombardi, G., Mannelli, M., Pacini, F., Ponder, B.A.J., Raue, F., Skogseid, B., Tamburrano, G., Thakker, R.V., Thompson, N.W., Tomassetti, P., Tonelli, F., Wells, S.A., J.R. Marx, S.J. (2001) Consensus: Guidelines for diagnosis and therapy of MEN type 1 and type 2. Journal of Clinical Endocrinology and Metabolism, 86, 5658 5671.
9. Heshmati, H.M., Gharib, H.G., Khosla, S., Abu-Lebdeh, H.S., Lindor, N.M. Thibodeau, S.N. (1997) Genetic testing in medullary thyroid carcinoma syndromes: mutation types and clinical significance. Mayo Clinic Proceedings, 72, 430 436.
10. Marsh, D.J., Mulligan, M.L. Eng, C. (1997) RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Hormone Research, 47, 168 178.
11. Mulligan, L.M., Eng, C., Healey, C.S., Clayton, D., Kwok, J.B.J., Gardner, E., Ponder, M.A., Frilling, A., Jackson, C.E., Lehnert, H., Neumann, H.P.H., Thibodeau, S.N. Ponder, B.A.J. (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genetics, 6, 70 74.
12. Gimm, O., Marsh, D.J., Andrew, S.D., Frilling, A., Dahia, P.L., Mulligan, L.M., Zajac, J.D., Robinson, B.G. Eng, C. (1997) Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. Journal of Clinical Endocrinology and Metabolism, 82, 3902 3904.
13. Smith, D.P., Houghton, C. Ponder, B.A. (1997) Germline mutation of RET codon 883 in two cases of de novo MEN 2B. Oncogene, 15, 1213 1217.
14. Punales, M.K., Graf, H., Gross, J.L. Maia, A.L. (2003) RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome. Journal of Clinical Endocrinology and Metabolism, 88, 2644 2649.
15. Brauckhoff, M., Gimm, O., Weiss, C.L., Ukkat, J., Sekulla, C., Brauckhoff, K., Thanh, P.N. Dralle, H. (2004) Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World Journal of Surgery, 28, 1305 1311.
16. Leboulleux, S., Travagli, J.P., Caillou, B., Laplanche, A., Bidart, J.M., Schlumberger, M. Baudin, E. (2002) Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome. Cancer, 94, 44 50.
17. Raue, F., Kraimps, J.L., Dralle, H., Cougard, P., Proye, C., Frilling, A., Limbert, E., Llenas, L.F. Niederle, B. (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. Journal of Internal Medicine, 238, 369 373.
18. Karga, H.J., Karayianni, M.K., Linos, D.A., Tseleni, S.C., Karaiskos, K.D. Papapetrou, P.D. (1998) Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma. European Journal of Endocrinology, 139, 410 415.
19. Gertner, M.E. Kebebew, E. (2004) Multiple endocrine neoplasia type 2. Current Treatment Options in Oncology, 5, 315 325.
20. Feldman, G.L., Edmonds, M.W., Ainsworth, P.J., Schuffenecker, I., Lenoir, G.M., Saxe, A.W., Talpos, G.B., Roberson, J., Petrucelli, N. Jackson, C.E. (2000) Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG→ATG) mutation. Surgery, 128, 93 98.
21. 21Lombardo, F., Baudin, E., Chiefari, E., Arturi, F., Bardet, S., Caillou, B., Conte, C., Dallapiccola, B., Giuffrida, D., Bidart, J.M., Schlumberger, M. Filetti, S. (2002) Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804. Journal of Clinical Endocrinology and Metabolism, 87, 1674 1680.